Highly active antiretroviral therapy associated with improved anemia among HIV-infected women

AIDS Patient Care and STDs

Volumn 15, Issue 9, 2001, Pages 473-480

  Semba, Richard D ^a   Shah, Nina ^b   Kleinmayer, Robert S Kenneth H ^c   Mayer, Kenneth H ^d   Schuman, Paula ^e   Gardner, Lytt I ^f   Vlahov, David ^b,g  

^a University School of Medicine   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d BROWN UNIVERSITY   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANEMIA; ANTIMICROBIAL THERAPY; ARTICLE; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORTALITY; PREVALENCE; REGRESSION ANALYSIS;

ADULT; ANEMIA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BALTIMORE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; MICHIGAN; NEW YORK CITY; PREVALENCE; RHODE ISLAND; WOMEN'S HEALTH;

EID: 0034796780     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729101753145466     Document Type: Article

References (29)

1. Hematologic abnormalities in the acquired immune deficiency syndrome
2. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men
3. Human immunodeficiency virus infection, anemia, and survival
4. The pathogenesis of anemia during human immunodeficiency virus infection
5. Hematologic abnormalities in AIDS
6. Consensus statement: Anemia in HIV infection - Current trends, treatment options, and practice strategies
7. Serum immunoreactive erythropoietin in HIV-infected patients
8. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow
9. The influence of human immunodeficiency virus-1 on hematopoiesis
10. Hematologic effects of AIDS therapies
11. Combination antiretroviral therapy including a protease inhibitor eliminated the transfusion requirements of HIV-infected individuals with anemia of chronic disease
12. Improvement of anemia among HIV-infected injection drug users on highly active antiretroviral therapy (HAART)
13. Design and baseline participant characteristics of the human immunodeficiency virus epidemiology research (HER) study: A prospective cohort study of human immunodeficiency virus infection in US women
14. +cell count, and HIV-1 plasma viral load
15. Anti-retroviral therapy in adults: Updated recommendations of the International AIDS Society - USA Panel
16. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society - USA Panel
17. Unbalanced repeated-measures models with structure covariance matrices
18. Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea
19. Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy
20. The anaemia of infection
21. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1
22. HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era
23. Natural history of HIV infection in the era of combination antiretroviral therapy
24. Inadequate erythropoietin response to anaemia in HIV patients: Relationship to serum levels of tumor necrosis factor-alpha, interleukin-6 and their soluble receptors
25. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells
26. Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients
27. +cells
28. Micronutrients and the pathogenesis of human immunodeficiency virus infection